Pacer Advisors Inc. increased its holdings in shares of USANA Health Sciences, Inc. (NYSE:USNA – Free Report) by 16.5% during the third quarter, Holdings Channel.com reports. The fund owned 544,256 shares of the company’s stock after purchasing an additional 76,904 shares during the quarter. Pacer Advisors Inc.’s holdings in USANA Health Sciences were worth $20,638,000 as of its most recent filing with the SEC.
A number of other hedge funds have also bought and sold shares of the business. Pzena Investment Management LLC increased its position in USANA Health Sciences by 7.5% during the third quarter. Pzena Investment Management LLC now owns 1,049,610 shares of the company’s stock worth $39,801,000 after acquiring an additional 72,977 shares during the period. Dimensional Fund Advisors LP increased its position in USANA Health Sciences by 0.6% during the second quarter. Dimensional Fund Advisors LP now owns 683,158 shares of the company’s stock worth $30,907,000 after acquiring an additional 3,889 shares during the period. American Century Companies Inc. increased its position in USANA Health Sciences by 12.3% during the second quarter. American Century Companies Inc. now owns 159,782 shares of the company’s stock worth $7,229,000 after acquiring an additional 17,460 shares during the period. Assenagon Asset Management S.A. increased its position in USANA Health Sciences by 13.5% during the third quarter. Assenagon Asset Management S.A. now owns 124,008 shares of the company’s stock worth $4,702,000 after acquiring an additional 14,756 shares during the period. Finally, Jacobs Levy Equity Management Inc. increased its position in USANA Health Sciences by 2.6% during the first quarter. Jacobs Levy Equity Management Inc. now owns 111,492 shares of the company’s stock worth $5,407,000 after acquiring an additional 2,820 shares during the period. 54.25% of the stock is owned by institutional investors.
Insider Buying and Selling at USANA Health Sciences
In other news, Director Gilbert A. Fuller sold 675 shares of the firm’s stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $37.71, for a total value of $25,454.25. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 0.33% of the company’s stock.
USANA Health Sciences Stock Up 1.4 %
USANA Health Sciences (NYSE:USNA – Get Free Report) last released its earnings results on Tuesday, October 22nd. The company reported $0.56 EPS for the quarter, beating the consensus estimate of $0.49 by $0.07. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The firm had revenue of $200.22 million for the quarter, compared to analyst estimates of $208.45 million. During the same period last year, the firm earned $0.59 EPS. Equities analysts predict that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.
Wall Street Analysts Forecast Growth
Separately, DA Davidson lowered their price target on shares of USANA Health Sciences from $38.00 to $35.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 23rd.
Check Out Our Latest Stock Analysis on USANA Health Sciences
About USANA Health Sciences
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Featured Articles
- Five stocks we like better than USANA Health Sciences
- 3 Warren Buffett Stocks to Buy Now
- Tesla Investors Continue to Profit From the Trump Trade
- 10 Best Airline Stocks to Buy
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- Investing in Commodities: What Are They? How to Invest in Them
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA – Free Report).
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.